In short

J2353 is the HCPCS Level II code for injection, octreotide, depot form for intramuscular injection, 1 mg. CMS assigns NDCs for Octreotide Acetate and Sandostatin Lar Depot to it. One billing unit is 1 mg. The Medicare Part B payment limit is $211.321 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file
HCPCS codeJ2353
Billing unit1 mg
Descriptor
Injection, octreotide, depot form for intramuscular injection, 1 mg
Short descriptor
Octreotide injection, depot
Code set
HCPCS Level II, maintained by CMS
Effective
Jan 1, 2004

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file
Payment limit per unit$211.321
Per1 mg
Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 1 mg. For example, 100 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Enter the dose given to build the claim line.

NDCs billed under J2353

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 9 NDCs to J2353 for Octreotide Acetate and Sandostatin Lar Depot. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J2353 in the CMS ASP crosswalk
DrugNDC (11-digit)LabelerPackageBilling units per package
Octreotide Acetate00480-9257-08Teva Pharmaceuticals USA, Inc.110
Octreotide Acetate00480-9259-08Teva Pharmaceuticals USA, Inc.120
Octreotide Acetate00480-9262-08Teva Pharmaceuticals USA, Inc.130
Octreotide Acetate67457-0756-10Mylan Institutional LLC110
Octreotide Acetate67457-0759-20Mylan Institutional LLC120
Octreotide Acetate67457-0762-30Mylan Institutional LLC130
Sandostatin Lar Depot00078-0811-81Novartis Pharmaceuticals Corporation110
Sandostatin Lar Depot00078-0818-81Novartis Pharmaceuticals Corporation120
Sandostatin Lar Depot00078-0825-81Novartis Pharmaceuticals Corporation130

J2353: common questions

Is J2353 a CPT code?
No. J2353 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J2353?
CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 9 NDCs under J2353, for Octreotide Acetate and Sandostatin Lar Depot. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J2353?
$211.321 per 1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J2353?
One unit of J2353 is 1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 1 mg. J-code billing units.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in